The Associated Press reports in this post in DailyAdvance.com that the health insurer Humana has reported huge fourth quarter loss in earnings due to higher claim expenses from its stand-alone Medicare prescription drug plans, lower investment income and a loss in its commercial business. The company though, is forecasting a huge turnaround in 2009, with share earnings ranging from $5.90 to $6.10, compared to $3.83 at year end. Humana Chief Operating Officer Jim Murray even mentions:
"We're doing them much more vigorously and identifying new opportunities to evaluate data that makes us feel much more comfortable than we did at this point last year."
Is the expected turnaround for Humana feasible? What are your thoughts?
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
